Frances Arnold, Co-Founder of Gevo, Wins Nobel Prize
October 03 2018 - 3:30PM
Gevo, Inc. (NASDAQ: GEVO) announced today that
Professor Frances Arnold of the California Institute of Technology
has been awarded the 2018 Nobel Prize for Chemistry for her work on
“the directed evolution of enzymes.” Patrick R. Gruber, the
Chief Executive Officer of Gevo, said “This award is well deserved.
Frances has been a leader in the development of enzymes. Gevo
has been the beneficiary of her good work. She, with her
research group, developed some of the critical enzymes needed for
Gevo’s biological pathway to produce renewable resource-based
isobutanol. Her work helped to establish Gevo as a leader in
renewable resource based chemicals and fuels. We congratulate
her on her Nobel Prize, and for co-founding Gevo.”
About Gevo
Gevo is a next generation “low-carbon” fuel company focused on
the development and commercialization of renewable alternatives to
petroleum-based products. Low-carbon fuels reduce the carbon
intensity, or the level of greenhouse gas emissions, compared to
standard fossil-based fuels across their lifecycle. The most common
low-carbon fuels are renewable fuels. Gevo is focused on the
development and production of mainstream fuels like gasoline and
jet fuel using renewable feedstocks that have the potential to
lower greenhouse gas emissions at a meaningful scale and enhance
agricultural production, including food and other related products.
In addition to serving the low-carbon fuel markets, through Gevo’s
technology, Gevo can also serve markets for the production of
chemical intermediate products for solvents, plastics, and building
block chemicals. Learn more at our website: www.gevo.com.
Forward-Looking Statements
Certain statements in this press release may constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements relate to a variety of matters, including, without
limitation, statements related to Professor Arnold’s work and
contributions to Gevo and other statements that are not purely
statements of historical fact. These forward-looking statements are
made on the basis of the current beliefs, expectations and
assumptions of the management of Gevo and are subject to
significant risks and uncertainty. Investors are cautioned not to
place undue reliance on any such forward-looking statements. All
such forward-looking statements speak only as of the date they are
made, and Gevo undertakes no obligation to update or revise these
statements, whether as a result of new information, future events
or otherwise. Although Gevo believes that the expectations
reflected in these forward-looking statements are reasonable, these
statements involve many risks and uncertainties that may cause
actual results to differ materially from what may be expressed or
implied in these forward-looking statements. For a further
discussion of risks and uncertainties that could cause actual
results to differ from those expressed in these forward-looking
statements, as well as risks relating to the business of Gevo in
general, see the risk disclosures in the Annual Report on Form 10-K
of Gevo for the year ended December 31, 2017, as amended, and in
subsequent reports on Forms 10-Q and 8-K and other filings made
with the U.S. Securities and Exchange Commission by Gevo.
|
Investor and
Media Contact Shawn M. Severson Integra Investor Relations
+1 415-226-7747 gevo@integra-ir.com
|
Gevo (NASDAQ:GEVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gevo (NASDAQ:GEVO)
Historical Stock Chart
From Jul 2023 to Jul 2024